Related Experiment Video
Updated: Aug 13, 2026

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
Published on: April 18, 2025
[Digoxin in treatment of chronic insufficiency and changes of functional state of the pancreas]
Insights
This study highlights managing chronic heart insufficiency with concurrent pancreatic issues. Digoxin effectively improved heart function and pancreatic ultrasound results in patients with systolic heart insufficiency.
Area of Science:
- Cardiology
- Gastroenterology
- Pharmacology
Background:
- Combined cardiovascular and gastroenterological system damage presents complex clinical challenges.
- Chronic heart insufficiency (CHI) management requires consideration of co-existing conditions.
- Systolic and diastolic blood pressure components necessitate differential patient management.
Purpose of the Study:
- To investigate the impact of managing chronic heart insufficiency on the gastroenterological system, specifically the pancreas.
- To evaluate treatment strategies for patients with combined cardiovascular and pancreatic conditions.
- To determine the efficacy of digoxin in patients with systolic heart insufficiency and pancreatic congestion.
Main Methods:
- Observational study of patients with chronic heart insufficiency.
- Differential management based on systolic or diastolic blood pressure prevalence.
- Assessment of pancreatic congestion and ultrasound characteristics.
- Evaluation of treatment effects on left ventricular ejection factor.
Main Results:
- Systolic heart insufficiency (left ventricular ejection factor < 40%) was prevalent.
- Digoxin treatment demonstrated efficacy in patients with CHI and pancreatic congestion.
- Significant enhancement of left ventricular ejection factor was observed.
- Improvement in pancreatic ultrasound characteristics was noted post-treatment.
Conclusions:
- Digoxin is an effective treatment for chronic heart insufficiency with pancreatic congestion, particularly in systolic CHI.
- Differential management strategies are crucial for patients with combined cardiovascular and pancreatic diseases.
- Treatment of cardiac dysfunction can positively influence pancreatic health.
Abstract:
The article challenges the issue of combined damage of the cardiovascular and gastroenterological systems. It is recommended differentially manage patients with chorine heart insufficiency and prevalence of systolic or diastolic components of their blood pressure. The authors also consider influence of the treatment on a congestive pancreas. Prevalence of the systolic heart insufficiency (ventricular ejection factor less than 40%) have been observed among patients by the authors; digoxin have been found to be effective in treatment of patients with chronic heart insufficiency and congestive pancreas. Enhancement of left ventricular ejection factor and improvement of ultrasound characteristics of the pancreas have been observed following the treatment.
Related Concept Videos
Heart Failure Drugs: Inotropic Agents
Chronic Pancreatitis II: Collaborative Care
Assessment:
Chronic Pancreatitis I: Introduction
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Chronic Pancreatitis II: Pathophysiology
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
